Skip to content

Total Operating Expenses at other companies

Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$59.65M+26.0%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$112.33M+40.0%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$105.86M+41.7%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
$157.54M+11.1%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$125.28M+2.4%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$137.36M-5.6%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s total operating expenses?
Harmony Biosciences Holdings, Inc. (HRMY) reported total operating expenses of $133.58M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s total operating expenses changed year-over-year?
Harmony Biosciences Holdings, Inc.'s total operating expenses increased by 38.4% year-over-year, from $96.49M to $133.58M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s total operating expenses?
Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s total operating expenses has grown at a 29.8% compound annual growth rate (CAGR), from $162.39M to $461.64M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.